Monday, February 2, 2009

Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the U.S. Federal Trade Commission (FTC) and the State of California have filed a lawsuit in the United States District Court for the Central District of California alleging that the Company's 2006 patent lawsuit settlement with Solvay Pharmaceuticals Inc. related to AndroGel(R) 1% (testosterone gel) CIII is unlawful.

The details can be read here.

No comments: